Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-β Signal Pathway
Redox microenvironment in kidney tissue at 5 weeks after DXR injection in different groups of mice as indicated. (a) Effect of DAL on kidney MDA levels; (b) Effect of DAL on kidney GSH levels. The control and DAL treatment groups are compared with the DXR group. Values are statistically significant at ; the DXR group is compared with the control group. Values are statistically significant at .